Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Cardiology, Barmherzige Brüder Hospital Regensburg, Regensburg, Germany.
Department of Urology, St Elisabeth Hospital Straubing, Straubing, Germany.
Clin Genitourin Cancer. 2018 Dec;16(6):e1181-e1187. doi: 10.1016/j.clgc.2018.07.031. Epub 2018 Aug 11.
Our objective was to investigate whether patients with urologic tumors were aware of smoking as a risk factor for the development and progression of several urologic cancers and the extent of the medical education they had received. Another aim was to investigate whether gender or age influenced patients' willingness to change their smoking habits.
Patients with histologically malignant urologic tumors were enrolled in our questionnaire-based study from September 2013 to December 2014 in 2 urology departments. Patients were asked about their smoking habits and their general understanding of the relationship between smoking and the onset of cancer (urologic cancer and lung cancer). Also, the extent of information they had acquired from a physician was assessed. The descriptive and oncologic data of the patients were recorded.
Of 258 enrolled patients, 186 (72.1%) had never had an informational discussion with a doctor about smoking and their urologic tumor disease. Of the 160 active and former smokers, only 45 (28.1%) were planning to stop or reduce smoking because of their tumor disease. The willingness to change smoking habits was greater for women, with a statistically significant difference (odds ratio, 5.59; P = .002). Younger patients aged <58 years were also more willing to reduce or stop smoking.
In our study, most patients with urologic cancer were unaware of smoking as the most probable cause of tumor development. The patients had not received proper counseling from doctors on smoking and the risk it poses for tumor progression. Efforts to balance compliance among the genders and age groups through risk-adapted counseling should be undertaken.
我们的目的是调查患有泌尿系统肿瘤的患者是否了解吸烟是导致多种泌尿系统癌症发生和发展的危险因素，以及他们接受的医学教育程度。另一个目的是调查性别或年龄是否影响患者改变吸烟习惯的意愿。
2013 年 9 月至 2014 年 12 月，我们在 2 个泌尿科部门对经组织学证实患有恶性泌尿系统肿瘤的患者进行了这项基于问卷的研究。患者被问及他们的吸烟习惯以及他们对吸烟与癌症（泌尿系统癌症和肺癌）发病之间关系的总体认识。同时，还评估了他们从医生那里获得的信息程度。记录了患者的描述性和肿瘤学数据。
在纳入的 258 例患者中，186 例（72.1%）从未与医生就吸烟和他们的泌尿系统肿瘤疾病进行过信息讨论。在 160 名活跃和曾经的吸烟者中，只有 45 名（28.1%）因肿瘤疾病而计划戒烟或减少吸烟。女性改变吸烟习惯的意愿更强，差异具有统计学意义（优势比，5.59；P =.002）。年龄<58 岁的年轻患者也更愿意减少或停止吸烟。
在我们的研究中，大多数患有泌尿系统癌症的患者都不知道吸烟是肿瘤发展的最可能原因。患者没有从医生那里得到关于吸烟及其对肿瘤进展风险的适当咨询。应该通过适应风险的咨询来努力平衡不同性别和年龄组的依从性。
